Signal Advisors Wealth LLC Has $1.42 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

Signal Advisors Wealth LLC boosted its stake in Johnson & Johnson (NYSE:JNJ) by 7.1% during the first quarter, Holdings Channel reports. The institutional investor owned 8,531 shares of the company’s stock after buying an additional 562 shares during the period. Signal Advisors Wealth LLC’s holdings in Johnson & Johnson were worth $1,415,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. ACT Wealth Management LLC acquired a new position in shares of Johnson & Johnson in the first quarter valued at approximately $223,000. MRA Advisory Group grew its holdings in Johnson & Johnson by 14.6% in the 1st quarter. MRA Advisory Group now owns 3,045 shares of the company’s stock valued at $505,000 after buying an additional 387 shares in the last quarter. Ullmann Wealth Partners Group LLC grew its holdings in Johnson & Johnson by 190.4% in the 1st quarter. Ullmann Wealth Partners Group LLC now owns 15,314 shares of the company’s stock valued at $2,540,000 after buying an additional 10,041 shares in the last quarter. Edge Wealth Management LLC grew its holdings in Johnson & Johnson by 2.2% in the 1st quarter. Edge Wealth Management LLC now owns 78,154 shares of the company’s stock valued at $12,961,000 after buying an additional 1,709 shares in the last quarter. Finally, Foster Group Inc. grew its stake in shares of Johnson & Johnson by 25.7% in the first quarter. Foster Group Inc. now owns 4,416 shares of the company’s stock valued at $732,000 after acquiring an additional 902 shares in the last quarter. Institutional investors and hedge funds own 69.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on JNJ. Morgan Stanley upped their price target on shares of Johnson & Johnson from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 16th. Leerink Partnrs lowered shares of Johnson & Johnson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, May 13th. Sanford C. Bernstein reissued a “market perform” rating on shares of Johnson & Johnson in a research report on Wednesday, April 16th. Raymond James reduced their price target on Johnson & Johnson from $165.00 to $162.00 and set an “outperform” rating on the stock in a research report on Monday, April 14th. Finally, Bank of America reduced their target price on Johnson & Johnson from $171.00 to $159.00 and set a “neutral” rating on the stock in a report on Thursday, April 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $170.88.

Johnson & Johnson Trading Up 0.9%

JNJ opened at $155.02 on Friday. The company’s 50 day moving average is $153.59 and its 200-day moving average is $153.68. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $169.99. The company has a current ratio of 1.11, a quick ratio of 0.86 and a debt-to-equity ratio of 0.43. The company has a market cap of $372.99 billion, a P/E ratio of 23.31, a PEG ratio of 2.56 and a beta of 0.42.

Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, April 15th. The company reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.59 by $0.18. Johnson & Johnson had a net margin of 18.20% and a return on equity of 34.24%. The firm had revenue of $21.89 billion for the quarter, compared to analyst estimates of $21.65 billion. Equities research analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 27th will be issued a dividend of $1.30 per share. This is an increase from Johnson & Johnson’s previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Tuesday, May 27th. This represents a $5.20 annualized dividend and a dividend yield of 3.35%. Johnson & Johnson’s dividend payout ratio (DPR) is 57.84%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.